Travere Therapeutics
TVTX
TVTX
130 hedge funds and large institutions have $964M invested in Travere Therapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 53 increasing their positions, 38 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 102.81% → 102.84% (+0.03%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
86% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $16.3M
Holders
130
Holding in Top 10
2
Calls
$2.32M
Puts
$16.3M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$9.73M | |
| 3 | +$7.04M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.92M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.28M |
Top Sellers
| 1 | -$38.4M | |
| 2 | -$9.82M | |
| 3 | -$6.5M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$5.26M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.21M |